Read Larry Connors' blog – Short Term Trading Strategies
Accordingly, Health Canada would like to remind healthcare providers and pharmacists of approved instructions for emergency compounding of Tamiflu capsules into liquid formulation found on page 16 of the product monograph for Tamiflu (http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/proj/monograph-rev/noticepm_avismp_2008-eng.php). The compounding procedure, which involves mixing the powder inside the capsules with a syrup, results in a 15 mg/mL suspension. The commercially available Tamiflu for Oral Suspension has a concentration of 12 mg/mL.
Dosing recommendations according to the Tamiflu Canadian product monograph for patients greater than 1 year of age and the dosing instructions for patients less than 1 year of age are summarized in the recently issued Health Professional Communication of October 13, 2009 (http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2009/tamiflu_2_hpc-cps-eng.php).
Pharmacists should also note that the Ora-Sweet SF sugar free oral syrup used in the emergency compounding may be experiencing increased demand in some locations. Paddock Laboratories, the manufacturer, reports that they have increased production to meet demands and are currently responding to outstanding orders.
For additional information, pharmacists should refer to the product monograph. Should pharmacists have any questions or require additional information regarding the use of Tamiflu, they should contact the Drug Information Department at Hoffman-LaRoche Limited at 1-888-762-4388 from 8:30 a.m. to 4:30 p.m. Monday to Friday Eastern Standard Time.
Pharmacists and Canadians requiring more information about this advisory can contact Health Canada's public inquiries line at (613) 957-2991, or call toll free at 1-866-225-0709.
Egalement disponible en francais
Contacts: Media Inquiries: Health Canada 613-957-2983 Public Inquiries: 613-957-2991 1-866-225-0709
SOURCE: Health Canada
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
